BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 34854585)

  • 21. Irreversible Electroporation Enhanced by Radiofrequency Ablation: An In Vitro and Computational Study in a 3D Liver Tumor Model.
    Fang Z; Mao H; Moser MAJ; Zhang W; Qian Z; Zhang B
    Ann Biomed Eng; 2021 Sep; 49(9):2126-2138. PubMed ID: 33594637
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Irreversible electroporation therapy in the management of locally advanced pancreatic adenocarcinoma.
    Martin RC; McFarland K; Ellis S; Velanovich V
    J Am Coll Surg; 2012 Sep; 215(3):361-9. PubMed ID: 22726894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Irreversible electroporation for unresectable hepatocellular carcinoma: initial experience and review of safety and outcomes.
    Cheung W; Kavnoudias H; Roberts S; Szkandera B; Kemp W; Thomson KR
    Technol Cancer Res Treat; 2013 Jun; 12(3):233-41. PubMed ID: 23369152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer cells ablation with irreversible electroporation.
    Miller L; Leor J; Rubinsky B
    Technol Cancer Res Treat; 2005 Dec; 4(6):699-705. PubMed ID: 16292891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ablation with irreversible electroporation in patients with advanced perihilar cholangiocarcinoma (ALPACA): a multicentre phase I/II feasibility study protocol.
    Coelen RJS; Vogel JA; Vroomen LGPH; Roos E; Busch ORC; van Delden OM; Delft FV; Heger M; van Hooft JE; Kazemier G; Klümpen HJ; van Lienden KP; Rauws EAJ; Scheffer HJ; Verheul HM; Vries J; Wilmink JW; Zonderhuis BM; Besselink MG; van Gulik TM; Meijerink MR
    BMJ Open; 2017 Sep; 7(9):e015810. PubMed ID: 28864693
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Irreversible Electroporation to Treat Unresectable Colorectal Liver Metastases (COLDFIRE-2): A Phase II, Two-Center, Single-Arm Clinical Trial.
    Meijerink MR; Ruarus AH; Vroomen LGPH; Puijk RS; Geboers B; Nieuwenhuizen S; van den Bemd BAT; Nielsen K; de Vries JJJ; van Lienden KP; Lissenberg-Witte BI; van den Tol MP; Scheffer HJ
    Radiology; 2021 May; 299(2):470-480. PubMed ID: 33724066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Irreversible Electroporation in Interventional Oncology: Where We Stand and Where We Go.
    Savic LJ; Chapiro J; Hamm B; Gebauer B; Collettini F
    Rofo; 2016 Aug; 188(8):735-45. PubMed ID: 27074423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Conceivable Mechanism Responsible for the Synergy of High and Low Voltage Irreversible Electroporation Pulses.
    Lv Y; Yao C; Rubinsky B
    Ann Biomed Eng; 2019 Jul; 47(7):1552-1563. PubMed ID: 30953220
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Induction of Combined Hyperthermal Ablation Effect of Irreversible Electroporation with Polydopamine Nanoparticle-Coated Electrodes.
    Jeon SM; Davaa E; Jenjob R; Pechyen C; Natphopsuk S; Jeong S; Yoo HJ; Yang SG
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An overview of the irreversible electroporation for the treatment of liver metastases: When to use it.
    Belfiore MP; De Chiara M; Reginelli A; Clemente A; Urraro F; Grassi R; Belfiore G; Cappabianca S
    Front Oncol; 2022; 12():943176. PubMed ID: 36119531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful ablation of lymph nodes using irreversible electroporation (IRE) in a porcine survival model.
    Fritz S; Sommer CM; Longerich T; Kuhn-Neureuther C; Radeleff B; Werner J; Hackert T
    Langenbecks Arch Surg; 2017 May; 402(3):465-473. PubMed ID: 28378237
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single-center nonrandomized clinical trial to assess the safety and efficacy of irreversible electroporation (IRE) ablation of liver tumors in humans: Short to mid-term results.
    Frühling P; Nilsson A; Duraj F; Haglund U; Norén A
    Eur J Surg Oncol; 2017 Apr; 43(4):751-757. PubMed ID: 28109674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Irreversible electroporation in the treatment of locally advanced pancreatic cancer].
    Záruba P; Hoskovec D; Lacman J; Hořejš J; Krška Z; Ryska M
    Rozhl Chir; 2015 Dec; 94(12):504-9. PubMed ID: 26767900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Irreversible electroporation for nonthermal tumor ablation in the clinical setting: a systematic review of safety and efficacy.
    Scheffer HJ; Nielsen K; de Jong MC; van Tilborg AA; Vieveen JM; Bouwman AR; Meijer S; van Kuijk C; van den Tol PM; Meijerink MR
    J Vasc Interv Radiol; 2014 Jul; 25(7):997-1011; quiz 1011. PubMed ID: 24656178
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Irreversible electroporation: the new generation of local ablation techniques for renal cell carcinoma].
    Liehr UB; Wendler JJ; Blaschke S; Porsch M; Janitzky A; Baumunk D; Pech M; Fischbach F; Schindele D; Grube C; Ricke J; Schostak M
    Urologe A; 2012 Dec; 51(12):1728-34. PubMed ID: 23139026
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Irreversible electroporation is a surgical ablation technique that enhances gene transfer.
    Au JT; Wong J; Mittra A; Carpenter S; Haddad D; Carson J; Jayaraman S; Monette S; Solomon SB; Ezell P; Fong Y
    Surgery; 2011 Sep; 150(3):474-9. PubMed ID: 21878233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Irreversible Electroporation For Hepatocellular Carcinoma: Longer-Term Outcomes At A Single Centre.
    Freeman E; Cheung W; Kavnoudias H; Majeed A; Kemp W; Roberts SK
    Cardiovasc Intervent Radiol; 2021 Feb; 44(2):247-253. PubMed ID: 33051707
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Percutaneous Irreversible Electroporation (IRE) of Hepatic Malignancy: A Bi-institutional Analysis of Safety and Outcomes.
    Mafeld S; Wong JJ; Kibriya N; Stenberg B; Manas D; Bassett P; Aslam T; Evans J; Littler P
    Cardiovasc Intervent Radiol; 2019 Apr; 42(4):577-583. PubMed ID: 30465255
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anaesthetic management during open and percutaneous irreversible electroporation.
    Nielsen K; Scheffer HJ; Vieveen JM; van Tilborg AA; Meijer S; van Kuijk C; van den Tol MP; Meijerink MR; Bouwman RA
    Br J Anaesth; 2014 Dec; 113(6):985-92. PubMed ID: 25173767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor Ablation Enhancement by Combining Radiofrequency Ablation and Irreversible Electroporation: An In Vitro 3D Tumor Study.
    Zhang B; Yang Y; Ding L; Moser MAJ; Zhang EM; Zhang W
    Ann Biomed Eng; 2019 Mar; 47(3):694-705. PubMed ID: 30565007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.